Skip to main content
Premium Trial:

Request an Annual Quote

UToronto Professor, Becton Dickinson Win Patents Related to Cell-Based Assays

Premium

Charles Boone, a professor at the University of Toronto, has been awarded US Patent No. 7,074,584, "Yeast arrays, methods of making such arrays, and methods of analyzing such arrays."

Boone is the sole inventor on the patent.

According to its abstract, the patent protects a method of detecting genetic interactions in yeast. The method can also be used to screen for function of biological effectors on yeast. The method encompasses crossing yeast strains with genetic alterations to acquire double mutants. The phenotypes of these double mutants are then checked to detect genetic interactions between them. The method can be used to assign function to yeast genes and their viral, prokaryotic, and eukaryotic homologs, and aptamers; and can also be used to study yeast two-hybrid interactions and to find genes that regulate certain yeast promoters, the abstract states.


Becton Dickinson has been awarded US Patent No. 7,074,615, "Peptides for enhanced cell attachment and cell growth."

Inventors listed on the patent are Bryce Chaney, Mohammad Heidaran, and Andrea Liebmann-Vinson.

According to its abstract, the patent protects cell adhesion-promoting peptide combinations that promote cell attachment or cell adhesion to culture surfaces that are otherwise cell adhesion resistant. The patent describes a combination of peptides that, when covalently coupled to a cell adhesion-resistant layer such as hyaluronic acid that has been created on a polystyrene surface, promote cell attachment, growth differentiation, and execution of other desired cellular functions in culture, the abstract states.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.